[Federal Register Volume 87, Number 189 (Friday, September 30, 2022)]
[Notices]
[Pages 59429-59430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21187]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-1150]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Generic Clearance for Lyme and other 
Tickborne Diseases Knowledge, Attitudes, and Practices Surveys'' to the 
Office of Management and budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on March 18, 2022 to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Lyme and other Tickborne Diseases Knowledge, Attitudes, and 
Practices Surveys (OMB Control Number 0920-1150, Exp. 9/30/2022)--
Revision--National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) Division of 
Vector-Borne Diseases (DVBD) and other programs working on tickborne 
diseases (TBDs) are requesting a Revision to a previously approved 
generic clearance to conduct TBD prevention studies to include 
knowledge, attitudes, and practices (KAP) surveys regarding ticks and 
tickborne diseases (TBDs) among residents and businesses offering pest 
control services in Lyme disease endemic areas of the United States. 
The data collection for which approval is sought will allow DVBD to use 
survey results to inform implementation of future TBD prevention 
interventions. The Revision involves a broadening of the secondary 
target population from owners and employees of pest control companies 
to stakeholders of local entities affected by TBDs (e.g., leaders in 
local public health or local government; owners or employees of pest 
control companies, landscaping companies, or other at-risk occupations; 
non-governmental organizations serving at-risk populations; and/or 
clinicians serving at-risk populations).
    TBDs are a substantial and growing public health problem in the 
United States. From 2004-2016, over 490,000 cases of TBDs were reported 
to CDC, including cases of anaplasmosis, babesiosis, ehrlichiosis, Lyme 
disease, Rocky Mountain spotted fever, and tularemia. Lyme disease 
accounted for 82% of all TBDs, with over 400,000 cases reported during 
this time period. Recent studies estimate nearly 500,000 cases of Lyme 
disease are diagnosed annually in the United States. In addition, 
several novel tickborne pathogens have recently been found to cause 
human disease in the United States. Factors driving the emergence of 
TBDs are not well defined and current prevention methods have been 
insufficient to curb the increase in cases. Data is lacking on how 
often certain prevention measures are used by individuals at risk, as 
well as what the barriers to using certain prevention measure are.
    The primary target population for these data collections are 
individuals and their household members who are at risk for TBDs 
associated with I.scapularis ticks and who may be exposed to these 
ticks residentially, recreationally, and/or occupationally. The 
secondary target population includes stakeholders of local entities 
affected by TBDs (e.g., leaders in local public health or local 
government; owners or employees of pest control companies, landscaping 
companies, or other at-risk occupations; non-governmental organizations 
serving at-risk populations; and/or clinicians serving at-risk 
populations) in areas where I. scapularis ticks transmit diseases to 
humans. Specifically, these target populations include those residing 
or working in the 15 highest incidence states for Lyme disease (CT, DE, 
ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI and WV). We anticipate 
conducting one to two surveys per year, for a maximum of six surveys 
conducted over a three-year period. Depending on the survey, we aim to 
enroll 500-10,000 participants per study. It is expected that we will 
need to target recruitment to about twice as many people as we intend 
to enroll. Surveys may be conducted daily, weekly, monthly, or bi-
monthly per participant for a defined period (whether by phone or web 
survey), depending on the survey or study. The surveys will range in 
duration from approximately 5-30 minutes. Each participant may be 
surveyed 1-64 times in one year; this variance is due to differences in 
the type of information collected for a given survey. Specific burden 
estimates for each study and each information collection instrument 
will be provided with each individual project submitted for OMB review. 
Insights gained from KAP surveys will aid in prioritizing which 
prevention methods should be evaluated in future randomized, controlled 
trials and ultimately help target promotion of proven prevention

[[Page 59430]]

methods that could yield substantial reductions in TBD incidence.
    CDC requests OMB approval for an estimated 98,830 annual burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
General public, individuals or          Screening instrument....          20,000               1           15/60
 households.
                                        Consent Form............          10,000               1           20/60
                                        Introductory Surveys....          10,000               1           30/60
                                        Monthly Surveys.........          10,000              12           15/60
                                        Final Surveys...........          10,000               1           30/60
                                        Daily Surveys...........          10,000              60            5/60
Stakeholders of local entities          Stakeholder Survey......           1,000               1           30/60
 affected by TBDs.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity,Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-21187 Filed 9-29-22; 8:45 am]
BILLING CODE 4163-18-P